SCHEMBL29942509

SCHEMBL29942509

O=C(OCc1ccccc1)N1CCN(CCOc2ccnc(N3C4CCC3CNC4)n2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS O95271 1/20 0.43
▸ PARP1 P09874 1/20 0.43
▸ TNKS2 Q9H2K2 1/20 0.43
▸ PARP2 Q9UGN5 1/20 0.43
▸ GRIN2B Q13224 7/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ CYP2C19 P33261 1/20 0.41
▸ CA1 P00915 2/20 0.40
▸ CA2 P00918 2/20 0.40
▸ CA7 P43166 2/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ ENPP2 Q13822 1/20 0.40
▸ CYP2D6 P10635 3/20 0.40
▸ CYP2C9 P11712 3/20 0.40
▸ FAAH O00519 1/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ HTR2C P28335 1/20 0.39
▸ CYP4F2 P78329 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23301181 1.00 TNKS (0.43) TNKSPARP1TNKS2PARP2GRIN2B
SCHEMBL23301259 0.90 GRIN2B (0.42) TNKSPARP1TNKS2PARP2GRIN2B
SCHEMBL21404913 0.86 GRIN2B (0.42) TNKSPARP1TNKS2PARP2GRIN2B
Hydrochloric Acid SCHEMBL29838286 0.85 GRIN2B (0.42) TNKSPARP1TNKS2PARP2GRIN2B
Hydrochloric Acid SCHEMBL21405075 0.85 GRIN2B (0.42) TNKSPARP1TNKS2PARP2GRIN2B
SCHEMBL28810491 0.85 ACHE (0.46) TNKSPARP1TNKS2PARP2GRIN2B
SCHEMBL29943772 0.85 ACHE (0.46) TNKSPARP1TNKS2PARP2GRIN2B
SCHEMBL23303178 0.81 KDM4E (0.49) SMN1; SMN2NPC1RAB9ACYP2C19CYP2D6
SCHEMBL23303123 0.81 ALDH1A1 (0.46) TNKSPARP1TNKS2PARP2GRIN2B
SCHEMBL29910708 0.81 ALDH1A1 (0.46) TNKSPARP1TNKS2PARP2GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4051674-A1 BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2022-09-07 — — EP disclosed
Send feedback